New Epidermal-Growth-Factor-Related Insights Into the Pathogenesis of Multiple Sclerosis: Is It Also Epistemology?
Recent findings showing that epidermal growth factor (EGF) is significantly decreased in the cerebrospinal fluid (CSF) and spinal cord (SC) of living or deceased multiple sclerosis (MS) patients, and that its repeated administration to rodents with chemically- or virally-induced demyelination of the...
Guardado en:
Autor principal: | Giuseppe Scalabrino |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8c15b374c6944a8c92ad801943df85b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Multiple sclerosis clinical and laboratory research.
-
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis
por: Rivera,Francisco J, et al.
Publicado: (2012) -
Primary Peripheral Epstein-Barr Virus Infection Can Lead to CNS Infection and Neuroinflammation in a Rabbit Model: Implications for Multiple Sclerosis Pathogenesis
por: Asma Hassani, et al.
Publicado: (2021) -
MICROBIAL AGENTS AS TRIGGERS OF MULTIPLE SCLEROSIS DEVELOPMENT
por: Yu. Froltsova, et al.
Publicado: (2019) -
A review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells
por: Shroff G
Publicado: (2018)